Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

LQDA

Liquidia Corp

Apr 25 • 10:35AM ET

12.11

Dollar change -0.44
Percentage change -3.51	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO DWAS VTWO PTH VHT IWN IWC

Index	RUT	P/E	-	EPS (ttm)	-1.21	Insider Own	26.73%	Shs Outstand	68.63M	Perf Week	-12.31%
Market Cap	920.72M	Forward P/E	-	EPS next Y	-0.53	Insider Trans	7.66%	Shs Float	55.70M	Perf Month	-23.93%
Income	-78.50M	PEG	-	EPS next Q	-0.32	Inst Own	47.13%	Short Float	14.50%	Perf Quarter	1.17%
Sales	17.49M	P/S	52.64	EPS this Y	5.30%	Inst Trans	-4.06%	Short Ratio	9.34	Perf Half Y	89.37%
Book/sh	0.69	P/B	17.57	EPS next Y	54.07%	ROA	-62.36%	Short Interest	8.07M	Perf Year	80.75%
Cash/sh	1.10	P/C	11.00	EPS next 5Y	-	ROE	-114.01%	52W Range	5.71 - 16.99	Perf YTD	0.67%
Dividend Est.	-	P/FCF	-	EPS past 5Y	30.44%	ROI	-158.09%	52W High	-28.72%	Beta	0.24
Dividend TTM	-	Quick Ratio	4.85	Sales past 5Y	423.30%	Gross Margin	76.18%	52W Low	112.08%	ATR (14)	0.76
Dividend Ex-Date	-	Current Ratio	4.85	EPS Y/Y TTM	-73.00%	Oper. Margin	-419.62%	RSI (14)	28.94	Volatility	5.79% 5.32%
Employees	136	Debt/Eq	0.07	Sales Y/Y TTM	9.75%	Profit Margin	-448.89%	Recom	1.57	Target Price	23.86
Option/Short	Yes / Yes	LT Debt/Eq	0.05	EPS Q/Q	-314.22%	Payout	-	Rel Volume	2.75	Prev Close	12.55
Sales Surprise	-4.30%	EPS Surprise	-81.66%	Sales Q/Q	-15.47%	Earnings	Mar 13 BMO	Avg Volume	864.62K	Price	12.11
SMA20	-15.78%	SMA50	-17.01%	SMA200	22.67%	Trades		Volume	496,184	Change	-3.51%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-05-24	Reiterated	Needham	Buy	$18 → $28
Sep-19-22	Resumed	Wedbush	Underperform	$3
Sep-01-22	Downgrade	Wedbush	Neutral → Underperform	$3
Jul-22-22	Initiated	Ladenburg Thalmann	Buy	$15
May-31-22	Initiated	BTIG Research	Buy	$14
May-26-22	Initiated	BofA Securities	Buy	$12
Dec-04-20	Initiated	H.C. Wainwright	Buy	$6
Nov-20-20	Downgrade	Wedbush	Outperform → Neutral	$20 → $4
Nov-08-18	Resumed	Jefferies	Buy
Sep-05-18	Initiated	Wedbush	Outperform	$26
Aug-20-18	Initiated	Needham	Buy	$30
Aug-20-18	Initiated	Jefferies	Buy	$22

Show Previous Ratings

Apr-02-24 09:00AM	Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-01-24 06:00AM	Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA (treprostinil) inhalation powder (GlobeNewswire)
Mar-20-24 01:50AM	Chief Medical Officer Rajeev Saggar Sells Shares of Liquidia Corp (LQDA) (GuruFocus.com)
01:49AM	Insider Sell: CFO and COO Michael Kaseta Sells 12,166 Shares of Liquidia Corp (LQDA) (GuruFocus.com)
Mar-16-24 02:42PM	Liquidia Corporation (NASDAQ:LQDA) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:54PM	Loading…
Mar-13-24 10:54PM	Q4 2023 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents) +5.36%
07:31AM	Liquidia Corp (LQDA) Reports Full Year 2023 Financial Results (GuruFocus.com)
07:10AM	Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
06:00AM	Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-06-24 06:30AM	Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024 (GlobeNewswire)
Feb-21-24 03:17PM	United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings (Benzinga)
06:51AM	UPDATE 3-United Therapeutics starts litigation with FDA over rival Liquidia's drug application (Reuters)
06:24AM	United Therapeutics, in unusual step, sues FDA over rivals drug application (BioPharma Dive)
Jan-30-24 06:30AM	Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress (GlobeNewswire)
Jan-29-24 09:55AM	Wall Street Analysts Think Liquidia Technologies, Inc. (LQDA) Could Surge 71.41%: Read This Before Placing a Bet (Zacks)
06:25AM	Loading…
Jan-25-24 06:25AM	UPDATE 1-US FDA still reviewing Liquidia's inhaled blood pressure drug (Reuters)
06:00AM	Liquidia Corporation Provides Update on New Drug Application for YUTREPIA (treprostinil) inhalation powder (GlobeNewswire)
Jan-19-24 06:30AM	Liquidia Corporation Announces Updates to Operations Leadership (GlobeNewswire)
Jan-09-24 06:21PM	Wall Street Analysts Believe Liquidia Technologies, Inc. (LQDA) Could Rally 29.94%: Here's is How to Trade (Zacks)
04:56PM	What Makes Liquidia Technologies, Inc. (LQDA) a Strong Momentum Stock: Buy Now? (Zacks)
Jan-08-24 08:22AM	Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims (GlobeNewswire)
Jan-05-24 06:45AM	Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD (GlobeNewswire)
Jan-04-24 09:10AM	Liquidia Corporation Announces $100 Million in New Financings (GlobeNewswire) +7.97%
Jan-02-24 06:45AM	Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-23 06:45AM	16 Most Promising Long-Term Stocks According to Analysts (Insider Monkey)
Dec-25-23 08:00AM	Biotech CEOs Are Buying Up Their Surging Stocks (Barrons.com)
Dec-22-23 06:35PM	Peabody Energy, Janus International, and More Stocks See Action From Activist Investors (Barrons.com)
Dec-20-23 04:56PM	U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 ('793 Patent) (GlobeNewswire) +35.70%
Dec-19-23 01:02PM	Insider Sell Alert: Chief Medical Officer Rajeev Saggar Sells 14,887 Shares of Liquidia Corp (LQDA) (GuruFocus.com) +5.63%
Dec-12-23 07:13AM	Liquidia Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
10:47AM	Loading…
Nov-08-23 10:47AM	Liquidia Corporation (NASDAQ:LQDA) Q3 2023 Earnings Call Transcript (Insider Monkey)
12:44AM	Q3 2023 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-07-23 07:07AM	Liquidia Corp (LQDA) Reports Q3 2023 Financial Results (GuruFocus.com)
06:30AM	Liquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-31-23 06:30AM	Liquidia Corporation to Report Third Quarter 2023 Financial Results on November 7, 2023 (GlobeNewswire)
Oct-02-23 07:00AM	Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors (GlobeNewswire)
Sep-25-23 04:09PM	FDA Accepts Submission to Add PH-ILD to YUTREPIA Label (GlobeNewswire)
Sep-06-23 04:30PM	United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent Office (GlobeNewswire)
Aug-13-23 05:22AM	Liquidia Corporation (NASDAQ:LQDA) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-11-23 12:38AM	Q2 2023 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents) -9.13%
Aug-10-23 07:15AM	Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
06:00AM	Liquidia Corporation Reports Second Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-03-23 08:17AM	Liquidia Corporation to Report Second Quarter 2023 Financial Results on August 10, 2023 (GlobeNewswire)
Jul-27-23 09:13AM	Liquidia Stock Down 12% But Insiders Still In US$74k Profit (Simply Wall St.)
06:00AM	Liquidia Submits Amendment to Add PH-ILD Indication to Tentatively Approved NDA for YUTREPIA (treprostinil) Inhalation Powder (GlobeNewswire)
Jul-25-23 02:37PM	Liquidia stock drops after setback in United Therapeutics dispute (American City Business Journals)
08:25AM	Silver Spring's United Therapeutics claims victory in patent infringement suit against Liquidia (American City Business Journals)
Jul-24-23 01:46PM	U.S. Federal Circuit Affirms All District Court Rulings in Patent Litigation (GlobeNewswire) -12.76%
Jun-29-23 11:24AM	Liquidia (LQDA) Up on Deal With Pharmosa to Co-Develop PH Drug (Zacks) -17.68%
Jun-28-23 05:36AM	Liquidia Corporation and Pharmosa Biopharm Announce Collaboration for Sustained-Release Inhaled Treprostinil Product in North America (GlobeNewswire) +10.99%
May-31-23 06:30AM	Liquidia Corporation to Present at the 2023 Jefferies Healthcare Conference (GlobeNewswire)
May-30-23 11:26AM	Investing in Liquidia (NASDAQ:LQDA) a year ago would have delivered you a 106% gain (Simply Wall St.)
May-21-23 03:39PM	Hero or Zero? 7 High-Risk Stocks to Make You Rich Or Broke. (InvestorPlace)
May-19-23 06:15AM	Liquidia Announces Poster Presentation at the 2023 American Thoracic Society International Conference (GlobeNewswire) +6.14%
May-09-23 06:33AM	Institutional investors are Liquidia Corporation's (NASDAQ:LQDA) biggest bettors and were rewarded after last week's US$60m market cap gain (Simply Wall St.)
May-04-23 09:15AM	Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:30AM	Liquidia Corporation Reports First Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
May-02-23 06:45AM	Liquidia Corporation to Present at BofA Securities 2023 Health Care Conference (GlobeNewswire)
Apr-27-23 06:45AM	Liquidia Corporation to Report First Quarter 2023 Financial Results on May 4, 2023 (GlobeNewswire)
Apr-20-23 04:17AM	Strength Seen in EyePoint Pharmaceuticals (EYPT): Can Its 9.6% Jump Turn into More Strength? (Zacks)
Apr-18-23 08:33AM	Liquidia Corporation's (NASDAQ:LQDA) Earnings Haven't Escaped The Attention Of Investors (Simply Wall St.)
Apr-11-23 06:45AM	Liquidia Corporation to Present at 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-03-23 06:45AM	Liquidia and GSK Restructure License to PRINT Technology for Inhaled Applications (GlobeNewswire)
Mar-25-23 08:33AM	Industry Analysts Just Made A Captivating Upgrade To Their Liquidia Corporation (NASDAQ:LQDA) Revenue Forecasts (Simply Wall St.)
Mar-20-23 04:10AM	Liquidia Corporation (NASDAQ:LQDA) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-18-23 08:34AM	Liquidia Full Year 2022 Earnings: Beats Expectations (Simply Wall St.)
Mar-17-23 03:22AM	Q4 2022 Liquidia Corp Earnings Call (Thomson Reuters StreetEvents)
Mar-16-23 07:55AM	Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +15.25%
06:30AM	Liquidia Corporation Reports Full Year 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-09-23 10:00AM	Liquidia Technologies, Inc. (LQDA) May Report Negative Earnings: Know the Trend Ahead of Q4 Release (Zacks) -5.41%
07:19AM	Liquidia Corporation to Report Full Year 2022 Financial Results on Thursday, March 16, 2023 (GlobeNewswire)
Feb-17-23 07:33AM	Insiders saw their US$2.6m investment bump up to US$4.2m after Liquidia Corporation (NASDAQ:LQDA) soared 15% last week (Simply Wall St.)
Feb-05-23 08:49PM	Decision moves Liquidia, United Therapeutics patent dispute toward resolution (American City Business Journals)
Feb-03-23 05:10AM	Strength Seen in Liquidia Technologies, Inc. (LQDA): Can Its 9.7% Jump Turn into More Strength? (Zacks)
Feb-02-23 04:39PM	Patent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (793 Patent) (GlobeNewswire) +9.70%
06:30AM	Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-09-23 10:01PM	Liquidia inks $100M financing agreement amid patent dispute (American City Business Journals)
06:30AM	Liquidia Enters Into a Revenue Interest Financing Agreement With HealthCare Royalty for Up to $100 Million (GlobeNewswire)
Dec-30-22 09:40AM	Are Medical Stocks Lagging Assertio (ASRT) This Year? (Zacks)
Dec-14-22 09:40AM	Are Medical Stocks Lagging Assertio (ASRT) This Year? (Zacks)
Dec-05-22 04:05PM	Liquidia Announces Collaboration to Develop a New Infusion Pump for Subcutaneous Delivery of Treprostinil Injection to Treat Pulmonary Arterial Hypertension (PAH) (GlobeNewswire) -5.65%
Dec-01-22 09:55AM	Wall Street Analysts Think Liquidia Technologies, Inc. (LQDA) Could Surge 153%: Read This Before Placing a Bet (Zacks) +5.78%
Nov-28-22 09:40AM	Is Liquidia Technologies (LQDA) Stock Outpacing Its Medical Peers This Year? (Zacks)
Nov-08-22 07:45AM	Liquidia Technologies, Inc. (LQDA) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
06:30AM	Liquidia Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-02-22 10:15AM	ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS (PR Newswire)
Nov-01-22 06:45AM	Liquidia to Report Third Quarter 2022 Financial Results on November 8, 2022 (GlobeNewswire) +5.93%
Oct-27-22 04:10PM	Precedential Opinion Panel Denies United Therapeutics Request for Review of 793 Inter Partes Review Decision (GlobeNewswire)
Oct-26-22 09:40AM	Are Medical Stocks Lagging Acadia Healthcare (ACHC) This Year? (Zacks)
Oct-17-22 06:30AM	Liquidia Announces Presentations at the CHEST 2022 Annual Meeting (GlobeNewswire)
Sep-26-22 06:45AM	7 Momentum Stocks to Buy Now for Extraordinary Gains (InvestorPlace)
Sep-10-22 08:24AM	Trade Alert: The CEO & Director Of Liquidia Corporation (NASDAQ:LQDA), Roger Jeffs, Has Just Spent US$244k Buying 2.6% More Shares (Simply Wall St.)
Sep-08-22 11:26AM	Liquidia (NASDAQ:LQDA) Is Using Debt Safely (Simply Wall St.) +5.87%
Sep-06-22 12:15PM	Liquidia faces delay for drug launch after ruling in United Therapeutics case (American City Business Journals)
Sep-02-22 05:58PM	Why Liquidia Stock Rocketed Nearly 21% Higher Today (Motley Fool) +20.58%
Aug-31-22 07:46PM	Liquidia Provides Update on Hatch-Waxman Litigation and to Host Call on September 1, 2022, at 8:00am E.T. (GlobeNewswire) +7.25%
09:55AM	Wall Street Analysts Believe Liquidia Technologies, Inc. (LQDA) Could Rally 136%: Here's is How to Trade (Zacks)
09:40AM	Is Liquidia Technologies (LQDA) Outperforming Other Medical Stocks This Year? (Zacks)
Aug-23-22 03:09PM	Find Highly-Ranked Cheap Stocks Under $10 to Buy with this Screen (Zacks)
12:00PM	Here's Why Liquidia Technologies, Inc. (LQDA) is a Great Momentum Stock to Buy (Zacks)

Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. It engages in novel products development used in PRINT technology to transform the lives of patients. The company was founded on June 28, 2020, and is headquartered in Morrisville, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Saggar Rajeev	Chief Medical Officer	Apr 19 '24	Sale	13.68	1,649	22,558	211,672	Apr 23 05:24 PM
JEFFS ROGER	Chief Executive Officer	Apr 12 '24	Sale	14.58	8,360	121,889	826,985	Apr 16 05:15 PM
Kaseta Michael	CFO and COO	Apr 12 '24	Sale	14.58	3,136	45,723	315,045	Apr 16 05:16 PM
Schundler Russell	General Counsel	Apr 12 '24	Sale	14.58	2,060	30,035	486,027	Apr 16 05:17 PM
Moomaw Scott	Chief Commercial Officer	Apr 12 '24	Sale	14.58	1,585	23,109	151,881	Apr 16 05:16 PM
Saggar Rajeev	Chief Medical Officer	Apr 12 '24	Sale	14.58	1,525	22,234	213,321	Apr 16 05:17 PM
Adair Jason	Chief Business Officer	Apr 12 '24	Sale	14.58	1,189	17,336	111,537	Apr 15 08:31 PM
JEFFS ROGER	Chief Executive Officer	Mar 18 '24	Sale	15.82	28,583	452,183	835,345	Mar 19 09:46 PM
Kaseta Michael	CFO and COO	Mar 18 '24	Sale	15.82	12,166	192,466	318,181	Mar 19 09:47 PM
Schundler Russell	General Counsel	Mar 18 '24	Sale	15.82	8,653	136,890	488,087	Mar 19 09:48 PM
Saggar Rajeev	Chief Medical Officer	Mar 18 '24	Sale	15.82	7,530	119,125	214,846	Mar 19 09:46 PM
Moomaw Scott	Chief Commercial Officer	Mar 18 '24	Sale	15.82	6,108	96,629	153,466	Mar 19 09:47 PM
Adair Jason	Chief Business Officer	Mar 18 '24	Sale	15.81	4,657	73,649	108,640	Mar 19 09:50 PM
Moomaw Scott	Chief Commercial Officer	Feb 29 '24	Sale	14.17	546	7,737	159,574	Mar 04 07:07 PM
Adair Jason	Chief Business Officer	Feb 29 '24	Sale	14.17	455	6,447	97,412	Mar 04 07:05 PM
Adair Jason	Chief Business Officer	Dec 18 '23	Sale	7.70	77	593	54,932	Dec 20 05:20 PM
Caligan Partners LP	Director	Dec 14 '23	Buy	7.16	1,117,318	7,999,997	11,280,945	Dec 14 04:42 PM
Manning Paul B	Director	Dec 14 '23	Buy	7.16	279,330	2,000,003	279,330	Dec 18 05:00 PM
JEFFS ROGER	Chief Executive Officer	Dec 14 '23	Buy	7.16	139,665	1,000,001	640,805	Dec 18 05:02 PM
Moomaw Scott	Chief Commercial Officer	Nov 30 '23	Sale	7.28	542	3,946	106,737	Dec 05 09:18 PM
Lippe Robert A	Chief Operations Officer	Nov 30 '23	Sale	7.28	497	3,618	193,788	Dec 05 09:21 PM
Adair Jason	Chief Business Officer	Nov 30 '23	Sale	7.28	452	3,291	54,478	Dec 05 09:15 PM
Adair Jason	Chief Business Officer	Sep 19 '23	Sale	6.51	75	488	53,637	Sep 20 06:14 PM
Moomaw Scott	Chief Commercial Officer	Aug 31 '23	Sale	6.88	537	3,695	105,404	Sep 05 08:10 PM
Lippe Robert A	Chief Operations Officer	Aug 31 '23	Sale	6.88	505	3,474	192,567	Sep 05 08:11 PM
Adair Jason	Chief Business Officer	Aug 31 '23	Sale	6.88	445	3,062	53,452	Sep 05 08:09 PM
Moomaw Scott	Chief Commercial Officer	May 31 '23	Sale	8.08	651	5,260	102,268	Jun 02 05:05 PM
Lippe Robert A	Chief Operations Officer	May 31 '23	Sale	8.08	597	4,824	189,646	Jun 02 05:03 PM

Open in Screener

AXSM

Axsome Therapeutics Inc

Apr 25 • 10:35AM ET

71.34

Dollar change +0.17
Percentage change 0.24	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

AXSM Axsome Therapeutics Inc daily Stock Chart

Held by: VTI VB IWM VXF VBK IWO IBB SCHA VTWO VHT

Index	RUT	P/E	-	EPS (ttm)	-5.20	Insider Own	18.14%	Shs Outstand	47.35M	Perf Week	8.55%
Market Cap	3.38B	Forward P/E	92.47	EPS next Y	0.77	Insider Trans	-0.66%	Shs Float	38.78M	Perf Month	-7.01%
Income	-239.24M	PEG	-	EPS next Q	-1.22	Inst Own	80.87%	Short Float	19.98%	Perf Quarter	-21.25%
Sales	270.60M	P/S	12.49	EPS this Y	28.79%	Inst Trans	16.51%	Short Ratio	10.71	Perf Half Y	11.96%
Book/sh	4.03	P/B	17.69	EPS next Y	120.56%	ROA	-52.02%	Short Interest	7.75M	Perf Year	0.15%
Cash/sh	8.15	P/C	8.75	EPS next 5Y	-	ROE	-159.21%	52W Range	55.02 - 98.40	Perf YTD	-10.37%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-35.53%	ROI	-63.61%	52W High	-27.50%	Beta	1.13
Dividend TTM	-	Quick Ratio	3.52	Sales past 5Y	88.16%	Gross Margin	87.43%	52W Low	29.66%	ATR (14)	3.29
Dividend Ex-Date	-	Current Ratio	3.63	EPS Y/Y TTM	-13.57%	Oper. Margin	-67.59%	RSI (14)	46.96	Volatility	5.47% 4.26%
Employees	545	Debt/Eq	0.98	Sales Y/Y TTM	440.80%	Profit Margin	-88.41%	Recom	1.31	Target Price	123.00
Option/Short	Yes / Yes	LT Debt/Eq	0.97	EPS Q/Q	-47.88%	Payout	-	Rel Volume	0.52	Prev Close	71.17
Sales Surprise	3.31%	EPS Surprise	-77.57%	Sales Q/Q	193.50%	Earnings	May 06 BMO	Avg Volume	723.41K	Price	71.34
SMA20	-0.97%	SMA50	-6.64%	SMA200	-4.63%	Trades		Volume	79,092	Change	0.24%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-19-24	Initiated	Robert W. Baird	Outperform	$108
Feb-06-24	Initiated	UBS	Buy	$111
Jan-25-24	Initiated	RBC Capital Mkts	Outperform	$126
Dec-13-23	Initiated	Citigroup	Buy	$125
Aug-08-23	Upgrade	BofA Securities	Underperform → Neutral	$59 → $81
Jan-05-23	Initiated	Piper Sandler	Neutral	$75
Nov-01-22	Initiated	Loop Capital	Buy	$95
Sep-07-22	Resumed	Mizuho	Buy	$49 → $76
Aug-10-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$105 → $34
Jun-10-21	Initiated	Berenberg	Buy	$112
Jan-08-21	Initiated	Jefferies	Buy	$129
Dec-16-20	Initiated	Mizuho	Buy	$120
Sep-29-20	Initiated	BofA Securities	Underperform	$66
Sep-10-20	Initiated	Morgan Stanley	Overweight	$102
Apr-28-20	Reiterated	H.C. Wainwright	Buy	$200 → $210
Apr-14-20	Initiated	Cowen	Outperform	$95
Dec-30-19	Reiterated	H.C. Wainwright	Buy	$170 → $200
Dec-17-19	Reiterated	H.C. Wainwright	Buy	$30 → $170
Dec-16-19	Reiterated	Guggenheim	Buy	$65 → $158
Oct-16-19	Initiated	Guggenheim	Buy	$48

Show Previous Ratings

Apr-22-24 09:16AM	15 Most Black States in the US (Insider Monkey)
Apr-15-24 07:00AM	Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting (GlobeNewswire)
Apr-10-24 07:00AM	Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6 (GlobeNewswire)
Apr-02-24 10:24AM	Axsome (AXSM) Begins Solriamfetol Binge Eating Phase III Study (Zacks)
12:17AM	Insider Sell: COO Mark Jacobson Sells 24,662 Shares of Axsome Therapeutics Inc (AXSM) (GuruFocus.com)
07:00AM	Loading…
Apr-01-24 07:00AM	Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder (GlobeNewswire)
Mar-27-24 07:44AM	3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List (InvestorPlace)
Mar-26-24 11:24AM	Axsome's (AXSM) Narcolepsy Drug Study Meets Primary Goal (Zacks)
06:24AM	30 Countries with the Lowest Depression Rates (Insider Monkey)
04:56AM	20 Cloudiest Cities in the U.S., Ranked (Insider Monkey)
Mar-25-24 07:00AM	Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients (GlobeNewswire)
06:30AM	Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy (GlobeNewswire)
Mar-23-24 06:45AM	Buying These Dirt-Cheap Stocks Could Be a Brilliant Move (Motley Fool)
Mar-22-24 10:00AM	Axsome Triumphs Over Major Depressive Disorder With Auvelity (GuruFocus.com)
Mar-21-24 11:30AM	Why Is Axsome (AXSM) Down 4% Since Last Earnings Report? (Zacks)
12:12PM	Loading…
Mar-20-24 12:12PM	Axsome (AXSM) Begins Dosing in Depression Study on Sunosi (Zacks)
Mar-19-24 07:00AM	Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder (GlobeNewswire) +5.97%
Mar-13-24 03:32PM	11 Oversold NASDAQ Stocks To Buy Right Now (Insider Monkey)
Mar-05-24 07:00AM	Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference (GlobeNewswire)
Feb-27-24 07:00AM	Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference (GlobeNewswire)
Feb-26-24 03:04PM	3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024 (InvestorPlace)
08:50AM	3 Biotech Stocks to Buy and Hold for the Next 10 Years (Motley Fool)
Feb-21-24 10:39AM	Axsome (AXSM) Stock Falls Despite Q4 Earnings & Revenue Beat (Zacks)
09:23AM	Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-20-24 10:39PM	Q4 2023 Axsome Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -12.57%
08:15AM	Axsome Therapeutics (AXSM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:31AM	Axsome Therapeutics Inc (AXSM) Reports Robust Revenue Growth in Q4 and Full Year 2023 (GuruFocus.com)
07:00AM	Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Feb-13-24 10:00AM	Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks) -5.51%
Feb-08-24 07:45AM	2 Stocks That Could Double Your Money in 5 Years (Motley Fool)
11:01AM	Loading…
Jan-23-24 11:01AM	Axsome Therapeutics Stock Showing Leadership, Earns 91 RS Rating (Investor's Business Daily)
07:00AM	Axsome Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20 (GlobeNewswire)
Jan-05-24 10:21AM	Axsome (AXSM) Stock Rises on Stellar Q4 Preliminary Results (Zacks)
Jan-04-24 07:00AM	Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated Milestones (GlobeNewswire) +7.75%
Jan-03-24 05:20AM	3 Stocks That Have Turned $50,000 Into More Than $500,000 in Just 5 Years (Motley Fool)
Jan-02-24 08:45AM	2 Biotech Stocks You Can Buy and Hold for the Next Decade (Motley Fool)
Jan-01-24 06:50AM	Prediction: These 3 Stocks Will Soar in 2024 (Motley Fool)
Dec-11-23 07:00AM	Axsome Therapeutics Presents New Data and Post-Hoc Analyses of Auvelity in Patients with Major Depressive Disorder at the American College of Neuropsychopharmacology (ACNP) 2023 Annual Meeting (GlobeNewswire)
Dec-10-23 06:56AM	3 Unstoppable Stocks to Buy Right Now (Motley Fool)
Dec-07-23 07:00AM	Axsome Therapeutics Hosts Solriamfetol Virtual Investor Event with Expert Thought Leaders Today (GlobeNewswire)
Nov-28-23 06:51PM	Axsome Therapeutics, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; December 7, 2023 deadline. (GlobeNewswire)
Nov-27-23 09:50AM	11 Best Upside Stocks To Buy Right Now (Insider Monkey) +5.93%
Nov-22-23 07:00AM	Axsome Therapeutics to Host Solriamfetol Virtual Investor Event on December 7 (GlobeNewswire)
05:30AM	3 Biotech Stocks That Could Be Millionaire Makers (Motley Fool)
Nov-21-23 07:00AM	Axsome Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Nov-11-23 06:50AM	3 Growth Stocks to Buy Right Now Without Any Hesitation (Motley Fool)
Nov-09-23 10:23AM	3 Healthcare Stocks That Have More Than Doubled in Value Since the Fed Started Raising Interest Rates (Motley Fool)
Nov-07-23 11:02AM	Axsome (AXSM) Q3 Loss Widens, Revenues Surpass Estimates (Zacks)
08:33AM	Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2023 Earnings Call Transcript (Insider Monkey)
02:23AM	Q3 2023 Axsome Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-06-23 08:09AM	Axsome Therapeutics Inc (AXSM) Reports 244% YoY Growth in 3Q 2023 Product Revenue (GuruFocus.com)
07:00AM	Axsome Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-02-23 07:00AM	Axsome Therapeutics and the Global Alzheimer's Disease Community Come Together in Raising Support for the Millions Affected by This Illness During Alzheimer's Disease Awareness Month 2023 (GlobeNewswire)
Oct-31-23 07:00AM	Axsome Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire)
Oct-27-23 05:00AM	Got $2,000? Here Are 2 Beaten-Down Growth Stocks to Buy Right Now (Motley Fool)
Oct-25-23 08:45AM	2 Biotech Stocks You Can Buy and Hold for the Next Decade (Motley Fool)
Oct-24-23 07:00AM	Axsome Therapeutics Presents Results of the ACCORD trial of AXS-05 in Alzheimer's Disease Agitation at the Clinical Trials on Alzheimer's Disease (CTAD) 2023 Conference (GlobeNewswire)
Oct-23-23 05:30AM	3 No-Brainer Stocks to Buy Right Now for Less than $100 (Motley Fool)
Oct-11-23 07:00AM	Axsome Therapeutics Appoints Dr. Sue Mahony to its Board of Directors (GlobeNewswire)
Oct-10-23 07:00AM	Axsome Therapeutics to Report Third Quarter 2023 Financial Results on November 6 (GlobeNewswire)
Oct-03-23 05:30AM	2 Top Biotech Stocks to Buy in October (Motley Fool)
Oct-02-23 07:00AM	Axsome Therapeutics Joins the National Alliance on Mental Illness and Others Advocating for the Importance of Mental Health on Mental Illness Awareness Week (GlobeNewswire)
Sep-21-23 07:00AM	Axsome Therapeutics Joins the Global Narcolepsy Community in Raising Awareness on World Narcolepsy Day (GlobeNewswire)
Sep-15-23 10:23AM	2 Top Biotech Stocks Defying the Bear Market (Motley Fool)
Sep-12-23 06:00AM	2 No-Brainer Biotech Stocks to Buy Right Now (Motley Fool)
Sep-07-23 07:03AM	Axsome Therapeutics Highlights Commitment to Innovating Treatments for Mental Health Conditions with Presentations at Psych Congress 2023 (GlobeNewswire)
Sep-05-23 07:00AM	Axsome Therapeutics to Present at Three Upcoming Investor Conferences (GlobeNewswire)
Aug-30-23 08:00AM	The Top Healthcare Stocks to Buy With $100 (Motley Fool)
Aug-24-23 10:07AM	These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy? (Motley Fool)
Aug-19-23 05:52AM	Got $200? 3 Growth Stocks to Buy That Could Double Your Money (Motley Fool)
Aug-10-23 05:50AM	3 Explosive Stocks to Buy Right Now (Motley Fool)
Aug-09-23 08:37AM	Axsome Therapeutics Second Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Aug-08-23 12:21PM	Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2023 Earnings Call Transcript (Insider Monkey)
10:02AM	DraftKings upgraded, Home Depot downgraded: Wall Street's top analyst calls (The Fly)
09:11AM	Axsome (AXSM) Q2 Earnings Beat, Stock Dips on Pipeline Updates (Zacks)
03:42AM	Q2 2023 Axsome Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 07:00AM	Axsome Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Aug-05-23 06:55AM	3 Fantastic Growth Stocks to Buy in August (Motley Fool)
Aug-03-23 09:45AM	Got $5,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond (Motley Fool)
Aug-02-23 10:23AM	Axsome Therapeutics, Inc. (NASDAQ:AXSM) Is Expected To Breakeven In The Near Future (Simply Wall St.) -5.26%
Jul-20-23 08:08AM	The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023 (InvestorPlace)
Jul-13-23 05:50AM	Got $500? 3 Growth Stocks to Buy That Could Double Your Money (Motley Fool)
Jul-12-23 07:00AM	Axsome Therapeutics to Report Second Quarter 2023 Financial Results on August 7 (GlobeNewswire)
Jul-11-23 10:00AM	Best Momentum Stocks to Buy for July 11th (Zacks)
Jul-07-23 07:00AM	Axsome Therapeutics Initiates FOCUS Phase 3 Trial of Solriamfetol for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults (GlobeNewswire)
Jul-01-23 05:45AM	5 Top Stocks for July (Motley Fool)
Jun-30-23 04:02PM	Axsome Therapeutics Announces Closing of Public Offering of $225 Million of Shares of Common Stock (GlobeNewswire)
Jun-28-23 03:59PM	Why Shares of Axsome Therapeutics Fell Wednesday (Motley Fool) -10.06%
09:28AM	Axsome Therapeutics Announces Pricing of Public Offering of $225 Million of Shares of Common Stock (GlobeNewswire)
09:25AM	As the Bull Roars, Shareholders Hate How These 2 Companies Are Selling Their Stock (Motley Fool)
07:45AM	2 Under-the-Radar Biotech Stocks to Buy in 2023 (Motley Fool)
05:30AM	The Best Stocks to Invest $20,000 in Right Now (Motley Fool)
Jun-27-23 08:24PM	Axsome Therapeutics Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Jun-25-23 06:07AM	3 Monster Stocks in the Making to Buy Right Now (Motley Fool)
Jun-22-23 06:40AM	3 Biotech Stocks to Buy as Companies Ink Major Deals (InvestorPlace)
Jun-20-23 08:23AM	Where Will Axsome Therapeutics Be in 3 Years? (Motley Fool)
Jun-17-23 05:17AM	Does an $11.5 Billion Opportunity Make This Growth Stock a Buy Now? (Motley Fool)
Jun-16-23 02:00PM	This Stock Crushed the Market Last Year. Here's Why It Could Do That Again. (Motley Fool)
Jun-15-23 02:00PM	Is Axsome Therapeutics Stock a Screaming Buy? (Motley Fool)
Jun-14-23 04:01PM	Axsome Therapeutics Expects Up To $11.5 Billion In Peak Sales, Wallops Analysts' Forecasts (Investor's Business Daily) +8.05%

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview contain AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jacobson Mark L.	Chief Operating Officer	Apr 01 '24	Option Exercise	1.30	24,662	32,061	24,662	Apr 01 06:46 PM
Jacobson Mark L.	Chief Operating Officer	Apr 01 '24	Sale	77.24	24,662	1,904,942	0	Apr 01 06:46 PM
JEFFS ROGER	Director	Mar 15 '24	Option Exercise	29.91	2,347	70,199	123,103	Mar 15 08:05 PM
JEFFS ROGER	Director	Mar 15 '24	Sale	71.61	2,347	168,062	120,756	Mar 15 08:05 PM
JEFFS ROGER	Director	Mar 14 '24	Option Exercise	24.01	29,976	719,787	137,732	Mar 15 08:05 PM
JEFFS ROGER	Director	Mar 14 '24	Sale	69.70	29,976	2,089,387	120,756	Mar 15 08:05 PM
Coleman Mark	Director	Sep 15 '23	Option Exercise	3.67	11,016	40,429	36,113	Sep 15 06:30 PM
Coleman Mark	Director	Sep 15 '23	Sale	75.18	18,572	1,396,189	403,856	Sep 15 06:30 PM
Coleman Mark	Director	Sep 15 '23	Sale	75.19	11,016	828,241	25,097	Sep 15 06:30 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

LQDA

Liquidia Corp

AXSM

Axsome Therapeutics Inc

Upgrade your FINVIZ experience